Share Price and Basic Stock Data
Last Updated: November 3, 2025, 8:52 pm
| PEG Ratio | -22.03 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Hindcon Chemicals Ltd operates in the chemicals industry, focusing on various specialized chemical products. The company’s stock price stood at ₹32.9, with a market capitalization of ₹168 Cr. In terms of revenue, Hindcon reported sales of ₹85.59 Cr for the fiscal year ending March 2023, a significant increase from ₹66.62 Cr in the previous fiscal year. However, the latest quarterly data indicates a downward trend, with sales declining to ₹14.34 Cr in March 2024 from ₹19.25 Cr in March 2023. This decline reflects the company’s transition phase as it adapts to market conditions. The trailing twelve months (TTM) revenue is reported at ₹58.55 Cr, showcasing variability in the company’s sales performance. The operating profit margin (OPM) for the latest fiscal year was 6.04%, slightly below the industry average, which suggests the need for improved operational efficiency. Overall, while Hindcon has shown robust growth historically, recent quarterly fluctuations indicate challenges ahead.
Profitability and Efficiency Metrics
Hindcon Chemicals recorded a net profit of ₹4.36 Cr for the fiscal year ending March 2023, with a profit margin of 5.08%. This figure demonstrates the company’s ability to maintain profitability despite fluctuating revenues. The return on equity (ROE) stood at 7.27%, while the return on capital employed (ROCE) was reported at 9.97%. These metrics indicate that while the company is generating returns, they are modest compared to higher-performing peers in the chemicals sector. The interest coverage ratio (ICR) reached an impressive 79.32x, highlighting the company’s strong ability to meet its interest obligations, particularly as it maintains low borrowings of ₹0.77 Cr. However, the cash conversion cycle (CCC) of 108.51 days suggests a prolonged period in converting inventories into cash, which may strain liquidity. The operating profit margin (OPM) of 11.42% in the latest fiscal year reflects some improvement, yet it still trails behind the sector’s average margins.
Balance Sheet Strength and Financial Ratios
The balance sheet of Hindcon Chemicals shows a solid foundation, with total assets reported at ₹63.58 Cr and total liabilities standing at ₹63.58 Cr as of March 2025. The company has maintained a low debt profile, with borrowings at just ₹0.77 Cr, resulting in a total debt-to-equity ratio of 0.01x, indicating minimal financial leverage. Reserves have grown to ₹46.35 Cr, enhancing the company’s equity base. The book value per share has also increased to ₹14.08, reflecting a healthy growth in shareholder equity. Furthermore, the current ratio is a robust 5.36x, suggesting a strong liquidity position. However, the price-to-book value ratio of 2.28x indicates that the stock may be trading at a premium compared to its underlying book value, which could raise concerns among value investors. Overall, while the balance sheet is strong, the valuation metrics suggest caution.
Shareholding Pattern and Investor Confidence
Hindcon Chemicals’ shareholding pattern reveals a strong promoter holding of 68.71% as of June 2025, reflecting significant insider confidence in the company’s future. The public holds 31.29% of the shares, while foreign institutional investors (FIIs) have no stake in the company, indicating a lack of international interest. This absence of FII participation could limit the stock’s liquidity and broader market appeal. The total number of shareholders has increased to 29,663, suggesting growing retail interest. However, the stagnation in FII investment may raise questions regarding the company’s attractiveness to institutional investors. Additionally, the increasing dividend payout ratio, which has risen to 60.55% for the fiscal year ending March 2025 from 0.00% in 2023, signals a commitment to returning value to shareholders, potentially enhancing investor confidence moving forward.
Outlook, Risks, and Final Insight
Looking ahead, Hindcon Chemicals faces both opportunities and challenges. The company’s strong balance sheet and low debt levels position it well for future growth, particularly if it can capitalize on operational efficiencies and improve its sales trajectory. However, risks remain, including fluctuations in raw material prices, which can impact margins, and the ongoing volatility in quarterly sales performance. Additionally, the high cash conversion cycle raises concerns about liquidity management. Should the company effectively address these risks through strategic initiatives, it could enhance profitability and shareholder value. Conversely, failure to adapt to market changes may hinder its growth prospects. The company’s ability to attract institutional investment, particularly from FIIs, will also be crucial in determining its long-term stability and market position.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Hindcon Chemicals Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Diamines & Chemicals Ltd | 263 Cr. | 270 | 577/256 | 159 | 165 | 0.37 % | 3.33 % | 1.78 % | 10.0 |
| Deco-Mica Ltd | 32.3 Cr. | 77.0 | 97.0/56.0 | 14.2 | 64.1 | 0.00 % | 11.8 % | 7.51 % | 10.0 |
| Andhra Sugars Ltd | 1,092 Cr. | 80.4 | 107/64.9 | 20.2 | 117 | 1.00 % | 3.54 % | 2.51 % | 2.00 |
| Tamil Nadu Petro Products Ltd | 1,119 Cr. | 124 | 130/63.6 | 15.6 | 101 | 0.96 % | 6.97 % | 5.10 % | 10.0 |
| SRF Ltd | 88,075 Cr. | 2,968 | 3,325/2,127 | 54.4 | 447 | 0.24 % | 12.3 % | 10.4 % | 10.0 |
| Industry Average | 14,390.22 Cr | 1,171.65 | 47.83 | 202.16 | 0.37% | 10.57% | 8.89% | 7.60 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 21.06 | 18.64 | 26.64 | 19.25 | 17.27 | 19.46 | 13.44 | 14.34 | 12.91 | 12.96 | 15.27 | 15.44 | 14.88 |
| Expenses | 19.79 | 18.19 | 24.86 | 17.59 | 14.18 | 18.44 | 12.25 | 12.55 | 11.18 | 12.71 | 14.06 | 14.40 | 13.18 |
| Operating Profit | 1.27 | 0.45 | 1.78 | 1.66 | 3.09 | 1.02 | 1.19 | 1.79 | 1.73 | 0.25 | 1.21 | 1.04 | 1.70 |
| OPM % | 6.03% | 2.41% | 6.68% | 8.62% | 17.89% | 5.24% | 8.85% | 12.48% | 13.40% | 1.93% | 7.92% | 6.74% | 11.42% |
| Other Income | 0.23 | 0.42 | 0.27 | 0.27 | 0.41 | 0.31 | 0.29 | 0.67 | 0.35 | 0.74 | 0.86 | -0.05 | 0.43 |
| Interest | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 | 0.03 | 0.01 | 0.02 | 0.00 | 0.02 | 0.01 | 0.05 | 0.04 |
| Depreciation | 0.07 | 0.07 | 0.07 | 0.08 | 0.06 | 0.07 | 0.08 | 0.14 | 0.19 | 0.20 | 0.20 | 0.23 | 0.21 |
| Profit before tax | 1.42 | 0.79 | 1.96 | 1.84 | 3.43 | 1.23 | 1.39 | 2.30 | 1.89 | 0.77 | 1.86 | 0.71 | 1.88 |
| Tax % | 28.17% | 31.65% | 27.55% | 26.63% | 25.66% | 30.08% | 27.34% | 21.74% | 30.16% | 23.38% | 25.81% | 22.54% | 28.19% |
| Net Profit | 1.04 | 0.54 | 1.41 | 1.36 | 2.55 | 0.88 | 1.01 | 1.80 | 1.31 | 0.58 | 1.37 | 0.55 | 1.35 |
| EPS in Rs | 0.20 | 0.11 | 0.27 | 0.26 | 0.49 | 0.17 | 0.20 | 0.35 | 0.25 | 0.11 | 0.27 | 0.11 | 0.26 |
Last Updated: August 20, 2025, 9:40 am
Below is a detailed analysis of the quarterly data for Hindcon Chemicals Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 14.88 Cr.. The value appears to be declining and may need further review. It has decreased from 15.44 Cr. (Mar 2025) to 14.88 Cr., marking a decrease of 0.56 Cr..
- For Expenses, as of Jun 2025, the value is 13.18 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 14.40 Cr. (Mar 2025) to 13.18 Cr., marking a decrease of 1.22 Cr..
- For Operating Profit, as of Jun 2025, the value is 1.70 Cr.. The value appears strong and on an upward trend. It has increased from 1.04 Cr. (Mar 2025) to 1.70 Cr., marking an increase of 0.66 Cr..
- For OPM %, as of Jun 2025, the value is 11.42%. The value appears strong and on an upward trend. It has increased from 6.74% (Mar 2025) to 11.42%, marking an increase of 4.68%.
- For Other Income, as of Jun 2025, the value is 0.43 Cr.. The value appears strong and on an upward trend. It has increased from -0.05 Cr. (Mar 2025) to 0.43 Cr., marking an increase of 0.48 Cr..
- For Interest, as of Jun 2025, the value is 0.04 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.05 Cr. (Mar 2025) to 0.04 Cr., marking a decrease of 0.01 Cr..
- For Depreciation, as of Jun 2025, the value is 0.21 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.23 Cr. (Mar 2025) to 0.21 Cr., marking a decrease of 0.02 Cr..
- For Profit before tax, as of Jun 2025, the value is 1.88 Cr.. The value appears strong and on an upward trend. It has increased from 0.71 Cr. (Mar 2025) to 1.88 Cr., marking an increase of 1.17 Cr..
- For Tax %, as of Jun 2025, the value is 28.19%. The value appears to be increasing, which may not be favorable. It has increased from 22.54% (Mar 2025) to 28.19%, marking an increase of 5.65%.
- For Net Profit, as of Jun 2025, the value is 1.35 Cr.. The value appears strong and on an upward trend. It has increased from 0.55 Cr. (Mar 2025) to 1.35 Cr., marking an increase of 0.80 Cr..
- For EPS in Rs, as of Jun 2025, the value is 0.26. The value appears strong and on an upward trend. It has increased from 0.11 (Mar 2025) to 0.26, marking an increase of 0.15.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 5:12 am
| Metric | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 32.83 | 32.34 | 33.81 | 35.28 | 44.40 | 44.07 | 44.27 | 66.62 | 85.59 | 64.51 | 56.59 | 58.55 |
| Expenses | 33.30 | 30.24 | 30.20 | 30.49 | 40.65 | 40.55 | 39.71 | 61.63 | 80.42 | 57.41 | 52.35 | 54.35 |
| Operating Profit | -0.47 | 2.10 | 3.61 | 4.79 | 3.75 | 3.52 | 4.56 | 4.99 | 5.17 | 7.10 | 4.24 | 4.20 |
| OPM % | -1.43% | 6.49% | 10.68% | 13.58% | 8.45% | 7.99% | 10.30% | 7.49% | 6.04% | 11.01% | 7.49% | 7.17% |
| Other Income | 2.03 | 0.09 | 0.35 | 0.98 | 0.57 | 1.00 | 2.15 | 1.37 | 1.19 | 1.68 | 1.89 | 1.98 |
| Interest | 0.79 | 0.68 | 0.67 | 0.52 | 0.23 | 0.09 | 0.08 | 0.02 | 0.05 | 0.08 | 0.08 | 0.12 |
| Depreciation | 0.27 | 0.21 | 0.18 | 0.14 | 0.13 | 0.14 | 0.18 | 0.25 | 0.29 | 0.35 | 0.82 | 0.84 |
| Profit before tax | 0.50 | 1.30 | 3.11 | 5.11 | 3.96 | 4.29 | 6.45 | 6.09 | 6.02 | 8.35 | 5.23 | 5.22 |
| Tax % | 32.00% | 34.62% | 32.80% | 22.31% | 28.03% | 33.33% | 25.89% | 30.05% | 27.74% | 25.39% | 26.58% | |
| Net Profit | 0.34 | 0.85 | 2.09 | 3.98 | 2.82 | 2.84 | 4.77 | 4.26 | 4.36 | 6.23 | 3.83 | 3.85 |
| EPS in Rs | 0.45 | 1.12 | 2.76 | 0.78 | 0.55 | 0.55 | 0.92 | 0.83 | 0.84 | 1.21 | 0.74 | 0.75 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 16.32% | 24.31% | 24.32% | 30.83% | 0.00% | 12.41% | 60.55% |
YoY Net Profit Growth
| Year | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 150.00% | 145.88% | 90.43% | -29.15% | 0.71% | 67.96% | -10.69% | 2.35% | 42.89% | -38.52% |
| Change in YoY Net Profit Growth (%) | 0.00% | -4.12% | -55.45% | -119.58% | 29.85% | 67.25% | -78.65% | 13.04% | 40.54% | -81.41% |
Hindcon Chemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2015-2016 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 5% |
| 3 Years: | -5% |
| TTM: | -3% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 27% |
| 5 Years: | 6% |
| 3 Years: | -3% |
| TTM: | -23% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 57% |
| 3 Years: | 30% |
| 1 Year: | -40% |
| Return on Equity | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 11% |
| 3 Years: | 10% |
| Last Year: | 8% |
Last Updated: September 5, 2025, 6:10 am
Balance Sheet
Last Updated: October 10, 2025, 2:11 pm
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.76 | 0.76 | 0.85 | 10.24 | 7.67 | 7.67 | 7.67 | 7.67 | 7.67 | 7.67 | 7.67 |
| Reserves | 10.69 | 11.50 | 14.23 | 15.47 | 22.42 | 24.67 | 27.78 | 31.47 | 34.68 | 42.28 | 46.35 |
| Borrowings | 8.92 | 5.28 | 5.02 | 0.82 | 0.18 | 0.30 | 0.99 | 1.24 | 0.98 | 0.00 | 0.77 |
| Other Liabilities | 4.43 | 6.30 | 5.94 | 6.60 | 5.95 | 6.73 | 6.78 | 12.23 | 10.31 | 9.62 | 8.79 |
| Total Liabilities | 24.80 | 23.84 | 26.04 | 33.13 | 36.22 | 39.37 | 43.22 | 52.61 | 53.64 | 59.57 | 63.58 |
| Fixed Assets | 0.93 | 0.92 | 1.11 | 1.08 | 1.00 | 1.13 | 1.41 | 1.72 | 2.57 | 6.25 | 7.11 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.39 | 0.00 | 0.00 |
| Investments | 0.28 | 0.66 | 0.81 | 3.24 | 4.32 | 4.47 | 2.79 | 3.21 | 2.19 | 4.66 | 4.76 |
| Other Assets | 23.59 | 22.26 | 24.12 | 28.81 | 30.90 | 33.77 | 39.02 | 47.68 | 48.49 | 48.66 | 51.71 |
| Total Assets | 24.80 | 23.84 | 26.04 | 33.13 | 36.22 | 39.37 | 43.22 | 52.61 | 53.64 | 59.57 | 63.58 |
Below is a detailed analysis of the balance sheet data for Hindcon Chemicals Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 7.67 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 7.67 Cr..
- For Reserves, as of Mar 2025, the value is 46.35 Cr.. The value appears strong and on an upward trend. It has increased from 42.28 Cr. (Mar 2024) to 46.35 Cr., marking an increase of 4.07 Cr..
- For Borrowings, as of Mar 2025, the value is 0.77 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 0.00 Cr. (Mar 2024) to 0.77 Cr., marking an increase of 0.77 Cr..
- For Other Liabilities, as of Mar 2025, the value is 8.79 Cr.. The value appears to be improving (decreasing). It has decreased from 9.62 Cr. (Mar 2024) to 8.79 Cr., marking a decrease of 0.83 Cr..
- For Total Liabilities, as of Mar 2025, the value is 63.58 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 59.57 Cr. (Mar 2024) to 63.58 Cr., marking an increase of 4.01 Cr..
- For Fixed Assets, as of Mar 2025, the value is 7.11 Cr.. The value appears strong and on an upward trend. It has increased from 6.25 Cr. (Mar 2024) to 7.11 Cr., marking an increase of 0.86 Cr..
- For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Investments, as of Mar 2025, the value is 4.76 Cr.. The value appears strong and on an upward trend. It has increased from 4.66 Cr. (Mar 2024) to 4.76 Cr., marking an increase of 0.10 Cr..
- For Other Assets, as of Mar 2025, the value is 51.71 Cr.. The value appears strong and on an upward trend. It has increased from 48.66 Cr. (Mar 2024) to 51.71 Cr., marking an increase of 3.05 Cr..
- For Total Assets, as of Mar 2025, the value is 63.58 Cr.. The value appears strong and on an upward trend. It has increased from 59.57 Cr. (Mar 2024) to 63.58 Cr., marking an increase of 4.01 Cr..
Notably, the Reserves (46.35 Cr.) exceed the Borrowings (0.77 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -9.39 | -3.18 | -1.41 | 3.97 | 3.57 | 3.22 | 3.57 | 3.75 | 4.19 | 7.10 | 3.47 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 199.90 | 204.51 | 199.50 | 189.43 | 159.56 | 164.24 | 158.38 | 144.42 | 111.65 | 125.83 | 139.38 |
| Inventory Days | 17.87 | 18.30 | 13.08 | 43.62 | 28.94 | 22.98 | 21.77 | 24.26 | 17.35 | 12.03 | 18.18 |
| Days Payable | 41.21 | 60.55 | 50.92 | 55.52 | 39.08 | 54.34 | 50.63 | 53.69 | 38.78 | 42.55 | 49.05 |
| Cash Conversion Cycle | 176.57 | 162.27 | 161.66 | 177.53 | 149.42 | 132.88 | 129.53 | 115.00 | 90.22 | 95.32 | 108.51 |
| Working Capital Days | 193.45 | 169.41 | 128.68 | 169.67 | 189.98 | 198.19 | 159.46 | 152.75 | 114.63 | 128.27 | 148.15 |
| ROCE % | 10.43% | 19.92% | 21.20% | 14.70% | 13.98% | 18.85% | 15.69% | 14.34% | 17.87% | 9.97% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 2.00 | 2.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 1.00 | 1.62 | 5.68 | 5.56 | 5.89 |
| Diluted EPS (Rs.) | 1.00 | 1.62 | 5.68 | 5.56 | 5.89 |
| Cash EPS (Rs.) | 1.21 | 1.72 | 6.05 | 5.89 | 6.19 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 14.08 | 13.18 | 55.83 | 51.61 | 47.51 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 14.08 | 13.18 | 55.83 | 51.61 | 47.51 |
| Revenue From Operations / Share (Rs.) | 14.75 | 16.82 | 111.57 | 86.83 | 57.85 |
| PBDIT / Share (Rs.) | 1.60 | 2.29 | 8.29 | 8.30 | 8.59 |
| PBIT / Share (Rs.) | 1.38 | 2.20 | 7.92 | 7.97 | 8.34 |
| PBT / Share (Rs.) | 1.36 | 2.18 | 7.85 | 7.94 | 8.32 |
| Net Profit / Share (Rs.) | 0.99 | 1.62 | 5.68 | 5.56 | 5.95 |
| NP After MI And SOA / Share (Rs.) | 0.99 | 1.61 | 5.63 | 5.51 | 5.89 |
| PBDIT Margin (%) | 10.82 | 13.61 | 7.43 | 9.55 | 14.84 |
| PBIT Margin (%) | 9.37 | 13.06 | 7.09 | 9.17 | 14.42 |
| PBT Margin (%) | 9.23 | 12.94 | 7.03 | 9.14 | 14.39 |
| Net Profit Margin (%) | 6.76 | 9.66 | 5.08 | 6.39 | 10.28 |
| NP After MI And SOA Margin (%) | 6.71 | 9.58 | 5.04 | 6.35 | 10.18 |
| Return on Networth / Equity (%) | 7.03 | 12.37 | 10.19 | 10.80 | 12.50 |
| Return on Capital Employeed (%) | 9.57 | 16.57 | 14.06 | 15.42 | 17.42 |
| Return On Assets (%) | 5.95 | 10.37 | 8.05 | 8.04 | 10.15 |
| Total Debt / Equity (X) | 0.01 | 0.00 | 0.02 | 0.03 | 0.02 |
| Asset Turnover Ratio (%) | 0.91 | 1.14 | 1.61 | 1.35 | 1.09 |
| Current Ratio (X) | 5.36 | 4.95 | 4.56 | 3.56 | 4.83 |
| Quick Ratio (X) | 5.13 | 4.77 | 4.24 | 3.29 | 4.57 |
| Inventory Turnover Ratio (X) | 32.11 | 13.20 | 14.54 | 11.99 | 11.21 |
| Dividend Payout Ratio (NP) (%) | 10.19 | 6.27 | 12.43 | 45.54 | 15.26 |
| Dividend Payout Ratio (CP) (%) | 8.38 | 5.93 | 11.65 | 42.97 | 14.66 |
| Earning Retention Ratio (%) | 89.81 | 93.73 | 87.57 | 54.46 | 84.74 |
| Cash Earning Retention Ratio (%) | 91.62 | 94.07 | 88.35 | 57.03 | 85.34 |
| Interest Coverage Ratio (X) | 79.32 | 116.14 | 126.44 | 284.21 | 447.20 |
| Interest Coverage Ratio (Post Tax) (X) | 50.61 | 83.43 | 87.60 | 191.32 | 310.80 |
| Enterprise Value (Cr.) | 110.57 | 188.47 | 51.83 | 49.65 | 9.63 |
| EV / Net Operating Revenue (X) | 1.95 | 2.92 | 0.60 | 0.74 | 0.21 |
| EV / EBITDA (X) | 18.06 | 21.47 | 8.15 | 7.80 | 1.46 |
| MarketCap / Net Operating Revenue (X) | 2.18 | 3.10 | 0.70 | 0.80 | 0.42 |
| Retention Ratios (%) | 89.80 | 93.72 | 87.56 | 54.45 | 84.73 |
| Price / BV (X) | 2.28 | 4.00 | 1.43 | 1.36 | 0.51 |
| Price / Net Operating Revenue (X) | 2.18 | 3.10 | 0.70 | 0.80 | 0.42 |
| EarningsYield | 0.03 | 0.03 | 0.07 | 0.07 | 0.24 |
After reviewing the key financial ratios for Hindcon Chemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 1.00. This value is below the healthy minimum of 5. It has decreased from 1.62 (Mar 24) to 1.00, marking a decrease of 0.62.
- For Diluted EPS (Rs.), as of Mar 25, the value is 1.00. This value is below the healthy minimum of 5. It has decreased from 1.62 (Mar 24) to 1.00, marking a decrease of 0.62.
- For Cash EPS (Rs.), as of Mar 25, the value is 1.21. This value is below the healthy minimum of 3. It has decreased from 1.72 (Mar 24) to 1.21, marking a decrease of 0.51.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 14.08. It has increased from 13.18 (Mar 24) to 14.08, marking an increase of 0.90.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 14.08. It has increased from 13.18 (Mar 24) to 14.08, marking an increase of 0.90.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 14.75. It has decreased from 16.82 (Mar 24) to 14.75, marking a decrease of 2.07.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 1.60. This value is below the healthy minimum of 2. It has decreased from 2.29 (Mar 24) to 1.60, marking a decrease of 0.69.
- For PBIT / Share (Rs.), as of Mar 25, the value is 1.38. This value is within the healthy range. It has decreased from 2.20 (Mar 24) to 1.38, marking a decrease of 0.82.
- For PBT / Share (Rs.), as of Mar 25, the value is 1.36. This value is within the healthy range. It has decreased from 2.18 (Mar 24) to 1.36, marking a decrease of 0.82.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 0.99. This value is below the healthy minimum of 2. It has decreased from 1.62 (Mar 24) to 0.99, marking a decrease of 0.63.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 0.99. This value is below the healthy minimum of 2. It has decreased from 1.61 (Mar 24) to 0.99, marking a decrease of 0.62.
- For PBDIT Margin (%), as of Mar 25, the value is 10.82. This value is within the healthy range. It has decreased from 13.61 (Mar 24) to 10.82, marking a decrease of 2.79.
- For PBIT Margin (%), as of Mar 25, the value is 9.37. This value is below the healthy minimum of 10. It has decreased from 13.06 (Mar 24) to 9.37, marking a decrease of 3.69.
- For PBT Margin (%), as of Mar 25, the value is 9.23. This value is below the healthy minimum of 10. It has decreased from 12.94 (Mar 24) to 9.23, marking a decrease of 3.71.
- For Net Profit Margin (%), as of Mar 25, the value is 6.76. This value is within the healthy range. It has decreased from 9.66 (Mar 24) to 6.76, marking a decrease of 2.90.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 6.71. This value is below the healthy minimum of 8. It has decreased from 9.58 (Mar 24) to 6.71, marking a decrease of 2.87.
- For Return on Networth / Equity (%), as of Mar 25, the value is 7.03. This value is below the healthy minimum of 15. It has decreased from 12.37 (Mar 24) to 7.03, marking a decrease of 5.34.
- For Return on Capital Employeed (%), as of Mar 25, the value is 9.57. This value is below the healthy minimum of 10. It has decreased from 16.57 (Mar 24) to 9.57, marking a decrease of 7.00.
- For Return On Assets (%), as of Mar 25, the value is 5.95. This value is within the healthy range. It has decreased from 10.37 (Mar 24) to 5.95, marking a decrease of 4.42.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.01. This value is within the healthy range. It has increased from 0.00 (Mar 24) to 0.01, marking an increase of 0.01.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.91. It has decreased from 1.14 (Mar 24) to 0.91, marking a decrease of 0.23.
- For Current Ratio (X), as of Mar 25, the value is 5.36. This value exceeds the healthy maximum of 3. It has increased from 4.95 (Mar 24) to 5.36, marking an increase of 0.41.
- For Quick Ratio (X), as of Mar 25, the value is 5.13. This value exceeds the healthy maximum of 2. It has increased from 4.77 (Mar 24) to 5.13, marking an increase of 0.36.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 32.11. This value exceeds the healthy maximum of 8. It has increased from 13.20 (Mar 24) to 32.11, marking an increase of 18.91.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 10.19. This value is below the healthy minimum of 20. It has increased from 6.27 (Mar 24) to 10.19, marking an increase of 3.92.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 8.38. This value is below the healthy minimum of 20. It has increased from 5.93 (Mar 24) to 8.38, marking an increase of 2.45.
- For Earning Retention Ratio (%), as of Mar 25, the value is 89.81. This value exceeds the healthy maximum of 70. It has decreased from 93.73 (Mar 24) to 89.81, marking a decrease of 3.92.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 91.62. This value exceeds the healthy maximum of 70. It has decreased from 94.07 (Mar 24) to 91.62, marking a decrease of 2.45.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 79.32. This value is within the healthy range. It has decreased from 116.14 (Mar 24) to 79.32, marking a decrease of 36.82.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 50.61. This value is within the healthy range. It has decreased from 83.43 (Mar 24) to 50.61, marking a decrease of 32.82.
- For Enterprise Value (Cr.), as of Mar 25, the value is 110.57. It has decreased from 188.47 (Mar 24) to 110.57, marking a decrease of 77.90.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.95. This value is within the healthy range. It has decreased from 2.92 (Mar 24) to 1.95, marking a decrease of 0.97.
- For EV / EBITDA (X), as of Mar 25, the value is 18.06. This value exceeds the healthy maximum of 15. It has decreased from 21.47 (Mar 24) to 18.06, marking a decrease of 3.41.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.18. This value is within the healthy range. It has decreased from 3.10 (Mar 24) to 2.18, marking a decrease of 0.92.
- For Retention Ratios (%), as of Mar 25, the value is 89.80. This value exceeds the healthy maximum of 70. It has decreased from 93.72 (Mar 24) to 89.80, marking a decrease of 3.92.
- For Price / BV (X), as of Mar 25, the value is 2.28. This value is within the healthy range. It has decreased from 4.00 (Mar 24) to 2.28, marking a decrease of 1.72.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.18. This value is within the healthy range. It has decreased from 3.10 (Mar 24) to 2.18, marking a decrease of 0.92.
- For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.03.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Hindcon Chemicals Ltd:
- Net Profit Margin: 6.76%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 9.57% (Industry Average ROCE: 10.57%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 7.03% (Industry Average ROE: 8.89%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 50.61
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 5.13
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 44.2 (Industry average Stock P/E: 47.83)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.01
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 6.76%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Others | No: 62/B, Braunfeld Row, Kolkata West Bengal 700027 | contactus@hindcon.com www.hindcon.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Sanjay Goenka | Chairman & Managing Director |
| Mrs. Nilima Goenka | Whole Time Director |
| Mr. Ramsanatan Banerjee | Whole Time Director |
| Mr. Binay Kumar Agarwal | Independent Director |
| Ms. Divyaa Newatia | Independent Director |
| Mr. Girdhari Lal Goenka | Independent Director |
FAQ
What is the intrinsic value of Hindcon Chemicals Ltd?
Hindcon Chemicals Ltd's intrinsic value (as of 03 November 2025) is 27.79 which is 16.04% lower the current market price of 33.10, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 170 Cr. market cap, FY2025-2026 high/low of 56.4/29.2, reserves of ₹46.35 Cr, and liabilities of 63.58 Cr.
What is the Market Cap of Hindcon Chemicals Ltd?
The Market Cap of Hindcon Chemicals Ltd is 170 Cr..
What is the current Stock Price of Hindcon Chemicals Ltd as on 03 November 2025?
The current stock price of Hindcon Chemicals Ltd as on 03 November 2025 is 33.1.
What is the High / Low of Hindcon Chemicals Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Hindcon Chemicals Ltd stocks is 56.4/29.2.
What is the Stock P/E of Hindcon Chemicals Ltd?
The Stock P/E of Hindcon Chemicals Ltd is 44.2.
What is the Book Value of Hindcon Chemicals Ltd?
The Book Value of Hindcon Chemicals Ltd is 10.6.
What is the Dividend Yield of Hindcon Chemicals Ltd?
The Dividend Yield of Hindcon Chemicals Ltd is 0.00 %.
What is the ROCE of Hindcon Chemicals Ltd?
The ROCE of Hindcon Chemicals Ltd is 9.97 %.
What is the ROE of Hindcon Chemicals Ltd?
The ROE of Hindcon Chemicals Ltd is 7.27 %.
What is the Face Value of Hindcon Chemicals Ltd?
The Face Value of Hindcon Chemicals Ltd is 2.00.